The pharmacology and clinical uses of tamoxifen

https://doi.org/10.1016/0163-7258(84)90043-3Get rights and content

First page preview

First page preview
Click to open first page preview

References (605)

  • L.J. Black et al.

    Differential interaction of antiestrogens with cytosol estrogen receptors

    Mol. cell. Endocr.

    (1981)
  • J. Bonté et al.

    Tamoxifen as a possible chemotherapeutic agent in endometrial adrenocarcinoma

    Gynec. Oncol.

    (1981)
  • J.L. Borgna et al.

    High affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite

    Molec. cell. Endocr.

    (1980)
  • J.L. Borgna et al.

    Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues

    J. biol. Chem.

    (1981)
  • M.M. Bouton et al.

    The relevance of kinetic parameters in the determination of specific binding to the estrogen receptor

    J. Steroid Biochem.

    (1978)
  • A.M.H. Brodie et al.

    Aromatase inhibitors and their use in controlling estrogen-dependent processes

    J. Steroid Biochem.

    (1979)
  • R.R. Brown et al.

    Determination of tamoxifen and metabolites in human serum by high performance liquid chromatography with post-column-fluorescence activation

    J. Chromat.

    (1983)
  • W.B. Butler et al.

    Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7)

    Biochem. biophys. Res. Commun.

    (1979)
  • F. Capony et al.

    High affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor

    Molec. cell. Endocr.

    (1978)
  • G. Chieffi et al.

    Effect of cyproterone acetate and ICI 46474 on gonadal sex differentiation in Rana esculenta

    Gen. comp. Endocr.

    (1974)
  • J.H. Clark et al.

    Estrogen receptor antiestrogen complex: atypical binding by uterine nuclei and effect on uterine growth

    Steroids

    (1973)
  • J.H. Clark et al.

    Heterogeneity of estrogen binding sites: relationship to estrogen receptors

    Recent Prog. Horm. Res.

    (1980)
  • J.H. Clark et al.

    The effect of clomid and other triphenylethylene derivatives during pregnancy and the neonatal period

    J. Steroid Biochem.

    (1980)
  • A.C. Abbott et al.

    Inhibition of oestradiol binding to oestrogen receptor proteins by a methyl-substituted analogue of tamoxifen

    J. Endocr.

    (1976)
  • H.K. Adam

    What we know and don't know about the pharmacokinetics of tamoxifen

  • H.K. Adam

    Pharmacokinetic studies with ‘Nolvadex’

    Revs Endocrine-related Cancer

    (1981)
  • H.K. Adam

    A review of the pharmacokinetics and metabolism of ‘Nolvadex’ (tamoxifen)

  • H.K. Adam et al.

    Measurement of tamoxifen in serum by thin layer densitometry

    J. Endocr.

    (1980)
  • H.K. Adam et al.

    Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers

    Cancer Treat. Rep.

    (1980)
  • E.Y. Adashi et al.

    Disparate effect of clomiphene and tamoxifen on pituitary gonadotropin release in vitro

    Am. J. Physiol.

    (1981)
  • B.L. Agrawal et al.

    Bone flare; hypercalcemia and jaundice after tamoxifen therapy

    Archs. intern. Med.

    (1981)
  • F.R. Ahman et al.

    Improved survival of patients with advanced breast cancer treated with adriamycin—cyclophosphamide plus tamoxifen

  • M.S. Aiyer et al.

    The role of sex steroid hormones in modulating the responsiveness of the anterior pituitary gland to luteinizing hormone releasing factor in the female rat

    J. Endocr.

    (1974)
  • T.C. Alford et al.

    Steroid hormone receptors in human colon cancers

    Cancer

    (1979)
  • J.C. Allegra et al.

    The regulation of progesterone receptor by 17β estradiol and tamoxifen in the ZR-75-1 human breast cancer cell line in defined medium

    J. Receptor Res.

    (1981)
  • J.C. Allegra et al.

    Growth of a human breast cancer cell line in serum free hormone supplemented medium

    Cancer Res.

    (1978)
  • K.E. Allen et al.

    Evidence for the metabolic activation of non-steroidal antioestrogens: A study of structure-activity relationships

    Br. J. Pharmac. Chemother.

    (1980)
  • M. Al-Sarraf et al.

    Study of tamoxifen in metastatic renal cell carcinoma and the influence of certain prognostic factors: a Southwest Oncology Group study

    Cancer Treat. Rep.

    (1981)
  • W.A. Al-Turk et al.

    Effect of tamoxifen treatment on liver, lung and intestinal mixed-function oxidases in male and female rats

    Drug Metab. Dispos.

    (1981)
  • J.N. Anderson et al.

    Oestrogen and nuclear binding sites by [3H] oestradiol exchange

    Biochem. J.

    (1972)
  • E.M. Armstrong et al.

    Ultrastructural demonstration of the mode of action of an anti-oestrogen (tamoxifen)

    Cytobios

    (1974)
  • D.J. Arnold et al.

    Tamoxifen flare

    J. Am. med. Ass.

    (1979)
  • D.J. Arnold et al.

    Tamoxifen therapy for metastatic prostate cancer

  • J. Arraztoa et al.

    Chemotherapy with and without manipulations in the treatment of advanced breast cancer

  • R.F. Aten et al.

    Kinetics of in vivo nuclear translocation of the male and female rat liver estrogen receptors

    Endocrinology

    (1980)
  • F. Auricchio et al.

    Dephosphorylation of oestradiol nuclear receptors in vitro

    Biochem. J.

    (1981)
  • J.G. Bainbridge et al.

    The role of oestrogen in spontaneous ovulation: location of site of action of positive feedback of oestrogen by intracranial implantation of the antioestrogen ICI 46474

    J. Endocr.

    (1971)
  • A. Bartke et al.

    Effects of tamoxifen on plasma concentrations of testosterone and gonadotrophins in the male rat

    J. Endocr.

    (1978)
  • G. Bartsch et al.

    Tamoxifen treatment in oligozoospermia

    Eur. Urol.

    (1981)
  • A.G.C. Bauer et al.

    The effect of tamoxifen on prolactin secretion in cirrhosis of the liver

  • Cited by (0)

    View full text